Amylyx Pharmaceuticals, Inc

BioNTech US Inc, based in Cambridge, MA, is a pioneering global immunotherapy company that focuses on developing innovative treatments aimed at combatting cancer, infectious diseases, and other serious health conditions. With its origins in Mainz, Germany, the company leverages a robust international network and a strong commitment to research and development to advance next-generation immunotherapies. Driven by scientific rigor and operational excellence, BioNTech is dedicated to unlocking the full potential of the immune system and enhancing the health of individuals worldwide. The company continually expands its global manufacturing capabilities to ensure equitable access to its innovative therapies. Generated from the website

Repligen Corporation develops novel therapeutics for the treatment of diseases of the central nervous and immune systems. It provides clinical development programs for the areas of schizophrenia, obsessive-compulsive disorder, bipolar disorder, multiple sclerosis and lupus. Repligen markets two niche products, Protein A and SecreFlo. Protein A is a consumable reagent used by the pharmaceutical industry to manufacture a class of drugs called monoclonal antibodies. The company offers a number of products based on recombinant Protein A, which include recombinant Protein A, Immobilized Protein A and Protein A ELISA Kits. SecreFlo is approved by the Food and Drug Administration to aid in the diagnosis of pancreatic exocrine dysfunction and gastrinoma and to aid in the identification and cannulation of the pancreatic ducts in patients undergoing endoscopic retrograde cholangiopancreatography. Repligen Corporation was established in 1981 and is headquartered in Waltham, Mass.

Nova Biomedical, based in Waltham, MA, specializes in the development, manufacturing, and sale of advanced analyzers across various healthcare sectors, including hospitals, critical care, and veterinary applications. The company's innovative product lineup features glucose and lactate monitoring systems, blood gas analyzers, and comprehensive solutions for cell culture analysis. Recently merged with Advanced Instruments, Nova Biomedical is committed to enhancing point-of-care testing and providing accurate results for medical professionals. The company continues to expand internationally, with significant investments in new technologies and global sales initiatives. Generated from the website